Stock Track | Legend Biotech Soars 5% as Company Announces Investor Event at ASCO Annual Meeting

Stock Track

05-20

Legend Biotech Corporation (LEGN) saw its stock price surge 5.00% in Monday's trading session, outperforming the broader market. The significant uptick in the company's shares comes as investors react positively to a recent announcement.

The biotech firm revealed plans to host a live webcast for investors on June 1, 2025, during the prestigious American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. This announcement appears to have sparked renewed interest in Legend Biotech's stock, driving the sharp increase in share price.

During the event, Legend Biotech's CEO Ying Huang, Ph.D., and CMO Mythili Koneru, M.D., Ph.D., along with expert clinicians, will present the latest updates from the company's CARTITUDE development program. This program is crucial to Legend Biotech's cell therapy pipeline, and new data could potentially impact the company's future prospects. The anticipation of these updates and the opportunity for investors to gain insights directly from the company's leadership seem to be the primary factors behind today's stock rally.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1126892586"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1126892586\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/1126892586?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-20 03:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1126892586","market":"sg","top_or_hot":-1,"title":"Stock Track | Legend Biotech Soars 5% as Company Announces Investor Event at ASCO Annual Meeting","media":"Stock Track","content":"<p>Legend Biotech Corporation (LEGN) saw its stock price surge 5.00% in Monday's trading session, outperforming the broader market. The significant uptick in the company's shares comes as investors react positively to a recent announcement.</p>\n\n<p>The biotech firm revealed plans to host a live webcast for investors on June 1, 2025, during the prestigious American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. This announcement appears to have sparked renewed interest in Legend Biotech's stock, driving the sharp increase in share price.</p>\n\n<p>During the event, Legend Biotech's CEO Ying Huang, Ph.D., and CMO Mythili Koneru, M.D., Ph.D., along with expert clinicians, will present the latest updates from the company's CARTITUDE development program. This program is crucial to Legend Biotech's cell therapy pipeline, and new data could potentially impact the company's future prospects. The anticipation of these updates and the opportunity for investors to gain insights directly from the company's leadership seem to be the primary factors behind today's stock rally.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Legend Biotech Soars 5% as Company Announces Investor Event at ASCO Annual Meeting</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Legend Biotech Soars 5% as Company Announces Investor Event at ASCO Annual Meeting\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time smaller\">2025-05-20 03:40</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Legend Biotech Corporation (LEGN) saw its stock price surge 5.00% in Monday's trading session, outperforming the broader market. The significant uptick in the company's shares comes as investors react positively to a recent announcement.</p>\n\n<p>The biotech firm revealed plans to host a live webcast for investors on June 1, 2025, during the prestigious American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. This announcement appears to have sparked renewed interest in Legend Biotech's stock, driving the sharp increase in share price.</p>\n\n<p>During the event, Legend Biotech's CEO Ying Huang, Ph.D., and CMO Mythili Koneru, M.D., Ph.D., along with expert clinicians, will present the latest updates from the company's CARTITUDE development program. This program is crucial to Legend Biotech's cell therapy pipeline, and new data could potentially impact the company's future prospects. The anticipation of these updates and the opportunity for investors to gain insights directly from the company's leadership seem to be the primary factors behind today's stock rally.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"","article_id":"1126892586","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1126892586","pubTimestamp":1747683626,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Legend Biotech Corporation  saw its stock price surge 5.00% in Monday's trading session, outperforming the broader market. The significant uptick in the company's shares comes as investors react positively to a recent announcement.The biotech firm revealed plans to host a live webcast for investors on June 1, 2025, during the prestigious American Society of Clinical Oncology  Annual Meeting in Chicago. This announcement appears to have sparked renewed interest in Legend Biotech's stock, driving ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"传奇生物科技(Legend Biotech)在ASCO年会上宣布投资者活动，股价飙升5%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LEGN":1},"content_text":"Legend Biotech Corporation (LEGN) saw its stock price surge 5.00% in Monday's trading session, outperforming the broader market. The significant uptick in the company's shares comes as investors react positively to a recent announcement.\nThe biotech firm revealed plans to host a live webcast for investors on June 1, 2025, during the prestigious American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. This announcement appears to have sparked renewed interest in Legend Biotech's stock, driving the sharp increase in share price.\nDuring the event, Legend Biotech's CEO Ying Huang, Ph.D., and CMO Mythili Koneru, M.D., Ph.D., along with expert clinicians, will present the latest updates from the company's CARTITUDE development program. This program is crucial to Legend Biotech's cell therapy pipeline, and new data could potentially impact the company's future prospects. The anticipation of these updates and the opportunity for investors to gain insights directly from the company's leadership seem to be the primary factors behind today's stock rally.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}